pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer.

[1]  C. Cone.  Unified theory on the basic mechanism of normal mitotic control and oncogenesis. , 1971, Journal of theoretical biology.

[2]  M. Tsao,et al.  Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. , 1996, The American journal of pathology.

[3]  M. Lazdunski,et al.  TWIK‐1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure. , 1996, The EMBO journal.

[4]  M. Lazdunski,et al.  TASK, a human background K+ channel to sense external pH variations near physiological pH , 1997, The EMBO journal.

[5]  T. Hwang,et al.  Genistein potentiates wild-type and delta F508-CFTR channel activity. , 1997, The American journal of physiology.

[6]  J. Ruppersberg,et al.  Interaction of permeant and blocking ions in cloned inward-rectifier K+ channels. , 1998, Biophysical journal.

[7]  A. Patel,et al.  Mechano- or Acid Stimulation, Two Interactive Modes of Activation of the TREK-1 Potassium Channel* , 1999, The Journal of Biological Chemistry.

[8]  B. Rudy,et al.  Identification and cloning of TWIK‐originated similarity sequence (TOSS): a novel human 2‐pore K+ channel principal subunit , 1999, FEBS letters.

[9]  M. Lazdunski,et al.  Human TREK2, a 2P Domain Mechano-sensitive K+Channel with Multiple Regulations by Polyunsaturated Fatty Acids, Lysophospholipids, and Gs, Gi, and Gq Protein-coupled Receptors* , 2000, The Journal of Biological Chemistry.

[10]  M. Tsao,et al.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. , 2000, The American journal of pathology.

[11]  E. Honoré,et al.  Properties and modulation of mammalian 2P domain K+ channels , 2001, Trends in Neurosciences.

[12]  P. Stanfield,et al.  TASK-5, a novel member of the tandem pore K+ channel family , 2001, Pflügers Archiv.

[13]  Daekyu Sun,et al.  Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells. , 2002, Experimental cell research.

[14]  R. Harvey,et al.  Genistein inhibits cardiac L-type Ca(2+) channel activity by a tyrosine kinase-independent mechanism. , 2002, Molecular pharmacology.

[15]  Gregory S Karczmar,et al.  MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  M. Lazdunski,et al.  K+-dependent Cerebellar Granule Neuron Apoptosis , 2003, Journal of Biological Chemistry.

[17]  Kohei Inamura,et al.  A Novel Two-pore Domain K+ Channel, TRESK, Is Localized in the Spinal Cord* , 2003, Journal of Biological Chemistry.

[18]  G. Czirják,et al.  Ruthenium red inhibits TASK-3 potassium channel by interconnecting glutamate 70 of the two subunits. , 2003, Molecular pharmacology.

[19]  M. Wigler,et al.  Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. , 2003, Cancer cell.

[20]  S. Grissmer,et al.  Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. , 2004, Molecular pharmacology.

[21]  W. Park,et al.  Altered expression of KCNK9 in colorectal cancers , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[22]  Donghee Kim,et al.  Functional Expression of TRESK-2, a New Member of the Tandem-pore K+ Channel Family* , 2004, Journal of Biological Chemistry.

[23]  M. Lazdunski,et al.  Pancreatic two P domain K+ channels TALK‐1 and TALK‐2 are activated by nitric oxide and reactive oxygen species , 2005, The Journal of physiology.

[24]  T. Neelands,et al.  BL-1249 [(5,6,7,8-Tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: A Putative Potassium Channel Opener with Bladder-Relaxant Properties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[25]  U. Carnegie.  Task 5 , 2005 .

[26]  N. Di Lorenzo,et al.  hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines , 2005, British Journal of Cancer.

[27]  J. Dobson,et al.  Expression of the mechanosensitive 2PK+ channel TREK‐1 in human osteoblasts , 2006, Journal of cellular physiology.

[28]  Albrecht Schwab,et al.  pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution , 2007, The Journal of physiology.

[29]  D. Lotshaw.  Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels , 2007, Cell Biochemistry and Biophysics.

[30]  E. Honoré,et al.  The neuronal background K2P channels: focus on TREK1 , 2007, Nature Reviews Neuroscience.

[31]  K. Hahn,et al.  Positive feedback between Cdc42 activity and H+ efflux by the Na-H exchanger NHE1 for polarity of migrating cells , 2007, The Journal of cell biology.

[32]  S. Almo,et al.  Acid-induced equilibrium folding intermediate of human platelet profilin. , 2007, Biochemistry.

[33]  R. Peri,et al.  High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology , 2008, Nature Reviews Drug Discovery.

[34]  C. Cordon-Cardo,et al.  TREK-1 is a novel molecular target in prostate cancer. , 2008, Cancer research.

[35]  E. Ficker,et al.  Regulation of two‐pore‐domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein , 2008, British journal of pharmacology.

[36]  F. Romero.  Solubilization and partial characterization of ouabain-insensitive Na(+)-ATPase from basolateral plasma membranes of the intestinal epithelial cells. , 2009, Investigacion clinica.

[37]  H. Kimelberg,et al.  TWIK-1 and TREK-1 Are Potassium Channels Contributing Significantly to Astrocyte Passive Conductance in Rat Hippocampal Slices , 2009, The Journal of Neuroscience.

[38]  Steve D. M. Brown,et al.  Genetic Inactivation of Kcnj16 Identifies Kir5.1 as an Important Determinant of Neuronal PCO2/pH Sensitivity* , 2010, The Journal of Biological Chemistry.

[39]  M. Falconi,et al.  Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[41]  F. Davis,et al.  Ion channels and transporters in cancer. 4. Remodeling of Ca(2+) signaling in tumorigenesis: role of Ca(2+) transport. , 2011, American journal of physiology. Cell physiology.

[42]  Albrecht Schwab,et al.  Intracellular pH gradients in migrating cells. , 2011, American journal of physiology. Cell physiology.

[43]  J. Barhanin,et al.  Molecular physiology of pH-sensitive background K(2P) channels. , 2011, Physiology.

[44]  P. Jonsson,et al.  The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells. , 2011, Molecular endocrinology.

[45]  H. Katus,et al.  Carvedilol targets human K2P3.1 (TASK1) K+ leak channels , 2011, British journal of pharmacology.

[46]  Markus Rapedius,et al.  The pore structure and gating mechanism of K2P channels , 2011, The EMBO journal.

[47]  A. Arcangeli,et al.  American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. , 2011, American journal of physiology. Cell physiology.

[48]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[49]  A. Schwab,et al.  Role of ion channels and transporters in cell migration. , 2012, Physiological reviews.

[50]  Roger Y. Tsien,et al.  Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires , 2012, Proceedings of the National Academy of Sciences.

[51]  J. Han,et al.  Reduction of breast cancer cell migration via up‐regulation of TASK‐3 two‐pore domain K+ channel , 2012, Acta physiologica.

[52]  A. Khandoker,et al.  Cardiac rehabilitation outcomes following a 6-week program of PCI and CABG Patients , 2013, Front. Physiol..

[53]  F. Mammano,et al.  A rapid and sensitive assay of intercellular coupling by voltage imaging of gap junction networks , 2013, Cell Communication and Signaling.

[54]  Jie Zheng.  Molecular mechanism of TRP channels. , 2013, Comprehensive Physiology.

[55]  I. O'kelly,et al.  Altered Expression of Two-Pore Domain Potassium (K2P) Channels in Cancer , 2013, PloS one.

[56]  William J. Brackenbury,et al.  Membrane potential and cancer progression , 2013, Front. Physiol..

[57]  I. Novak,et al.  Molecular basis of potassium channels in pancreatic duct epithelial cells , 2013, Channels.

[58]  Xian-Tao Li,et al.  Expression and localization of TASK-1, -2 and -3 channels in MG63 human osteoblast-like cells , 2012, Oncology letters.

[59]  D. Sauter,et al.  Genistein as Antiviral Drug against HIV Ion Channel , 2014, Planta Medica.

[60]  Z. Nagy,et al.  Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells , 2014, Archives of Dermatological Research.

[61]  D. Sauter,et al.  ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC) , 2014, Pflügers Archiv - European Journal of Physiology.

[62]  L. Pardo,et al.  The roles of K+ channels in cancer , 2013, Nature Reviews Cancer.

[63]  H. Klein,et al.  Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer , 2015, International journal of cancer.

[64]  J. Teulon,et al.  Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels. , 2015, Physiological reviews.

[65]  Neli I Panova-Elektronova,et al.  Parallel fiber to Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27 , 2015, Front. Cell. Neurosci..

[66]  Sigrid A. Langhans,et al.  Cancer as a channelopathy: ion channels and pumps in tumor development and progression , 2015, Front. Cell. Neurosci..

[67]  M. Lengyel,et al.  Differential sensitivity of TREK‐1, TREK‐2 and TRAAK background potassium channels to the polycationic dye ruthenium red , 2015, British journal of pharmacology.